STEK | tickerfilter.com

Fundamental analysis

21%

Profitability 18%

Dept financing 18%

Liquidity 0%

Performance 30%

Performance

5 Days

23.74%

1 Month

-30.00%

3 Months

-42.08%

6 Months

-51.00%

1 Year

-51.00%

2 Year

-51.00%

Key data

Stock price

$0.02

P/E Ratio

N/A

DAY RANGE

$0.02 - $0.03

EPS

N/A

52 WEEK RANGE

$0.02 - $0.05

52 WEEK CHANGE

-$51.00

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$224,363

AVERAGE 30 VOLUME

$475,426

Company detail

CEO:
Region: US
Website: stemtech.com
Employees: 0
IPO year: 2022

Issue type:
Market: OTCM
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Stemtech Corporation develops and sells various dietary supplements. It offers stemrelease3, a stem cell enhancer, which supports the body's natural renewal system, a general sense of wellbeing, and telomeres health, as well as promotes youthful and healthy aging. MigraStem, a natural source of potent antioxidants, phytonutrients, fiber, and polysaccharides, optimizes the migration of stem cells, enhance the immune system performance, support detoxification and anti-oxidative functions.

STEK - Stemtech Corp